Abstract:Boron-dipyrromethene (BODIPY) dyes have aroused considerable interest in cancer theranostics over the past decade because of robust photochemical properties. Although a large number of BODIPY photosensitizers (PSs) containing heavy atoms have been reported, the development of heavy-atom-free BODIPY PSs for oncologic photodynamic therapy (PDT) has been limited mainly by the uncertainty in intersystem crossing (ISC) mechanisms, unbalanced phototoxic effectiveness and fluorescence quantum yields, and aggregation-caused quenching effects. In addition, the lack of extensive in vivo studies of heavy-atom-free BODIPY PSs continues to limit clinical application. Herein, novel heavy-atom-free BODIPY-phenoxazine triads (BDP-8/BDP-9) that generate efficient excited triplet states via radical pair intersystem crossing (RP-ISC) followed by triplet charge recombination were developed for use in fluorescence image-guided PDT. BDP-8/BDP-9 exhibited high molar absorption coefficients, prominent aggregation-induced emission, and excellent singlet oxygen generation capability upon light irradiation. The corresponding BODIPY nanoparticles (BDP-8/BDP-9 NPs) with bright red emission, considerable phototoxicity, and excellent tumor-targeting ability were simply prepared by encapsulating BDP-8/BDP-9 PSs in a polymeric matrix. More importantly, the results of both in vitro and in vivo experiments demonstrated the considerable potential of BDP-8 NPs for image-guided photodynamic cancer therapy. This study may inspire the development of potential BODIPY-based nanoagents for cancer theranostics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.chemmater.1c02776.Experimental data; synthesis, nanoparticle preparation, photophysical measurements, and reactive oxygen species measurements of BDP-8/BDP-9; in vitro and in vivo studies of BDP-8/BDP-9 NPs; 1H and 13C NMR spectra of all compounds; UV–vis absorption and PL spectra; fluorescence images; computational details, calculated electronic transition energies; energy gap between single and triplet states; spin-orbit coupling constant; and intersystem crossing rate constant (PDF)This article has not yet been cited by other publications.

An Ethacrynic Acid-Brominated BODIPY Photosensitizer (EA-BPS) Construct Enhances the Lethality of Reactive Oxygen Species in Hypoxic Tumor-Targeted Photodynamic Therapy.

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

A BODIPY-modified polymeric micelle for sustaining enhanced photodynamic therapy

Type I Photosensitizer Based on AIE Chromophore Tricyano-Methylene-pyridine for Photodynamic Therapy

Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells

Access to the Triplet Excited States of Heavy-Atom-Free Boron-Dipyrromethene Photosensitizers via Radical Pair Intersystem Crossing for Image-Guided Tumor-Targeted Photodynamic Therapy

Photoinduced Carbene for Effective Photodynamic Therapy Against Hypoxic Cancer Cells

An Endoplasmic Reticulum Targeting Type I Photosensitizer for Effective Photodynamic Therapy against Hypoxic Tumor Cells

Acceptor Substitution Engineering of BODIPY-based Organic Photosensitizers with Aggregation-Induced Emission for Organelle Localization and Photodynamic Anticancer Therapy

Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondria

Potent BODIPY-based photosensitisers for selective mitochondrial dysfunction and effective photodynamic therapy

Efficient type I and type II ROS generated aggregation-induced emission photosensitizer for mitochondria targeted photodynamic therapy

A Combination of Covalent and Noncovalent Restricted-Intramolecular-rotation Strategy for Supramolecular AIE-type Photosensitizer Toward Photodynamic Therapy

Optimizing Photosensitizers with Type I and Type II ROS Generation Through Modulating Triplet Lifetime and Intersystem Crossing Efficiency

Smart Tumor‐Cell‐Derived Microparticles Provide On‐Demand Photosensitizer Synthesis and Hypoxia Relief for Photodynamic Therapy

Supramolecular Photosensitizer Enables Oxygen-Independent Generation of Hydroxyl Radicals for Photodynamic Therapy.

Auto-Deactivation of BODIPY-Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia.

pH-Sensitive and Lysosome Targetable Photosensitizers Based on BODIPYs

PEGylated BODIPY Photosensitizer for Type I Dominant Photodynamic Therapy and Afterglow Imaging

Binary Organic Nanoparticles with Enhanced Reactive Oxygen Species Generation Capability for Photodynamic Therapy

A red-light-activated sulfonamide porphycene for highly efficient photodynamic therapy against hypoxic tumor